Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-09-17 4:07 pm Purchase | 2026-09-10 | 13G | KIORA PHARMACEUTICALS INC KPRX | Baselake Partners, LP | 257,500 5.800% | 257,500 (New Position) | Filing History |
| 2026-08-14 5:00 pm Purchase | 2026-06-30 | 13G | KIORA PHARMACEUTICALS INC KPRX | ADAR1 Capital Management LLC | 475,378 9.900% | 110,199 (+30.18%) | Filing History |
| 2026-08-14 4:39 pm Purchase | 2026-06-30 | 13G | KIORA PHARMACEUTICALS INC KPRX | Nantahala Capital Management LLC | 491,889 9.990% | 53,420 (+12.18%) | Filing History |
| 2026-08-10 11:59 am Purchase | 2026-04-06 | 13G | KIORA PHARMACEUTICALS INC KPRX | Perceptive Advisors LLC | 442,387 9.990% | 3,916 (+0.89%) | Filing History |
| 2026-05-15 4:40 pm Purchase | 2026-03-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Nantahala Capital Management LLC | 438,469 9.990% | 74,757 (+20.55%) | Filing History |
| 2026-05-15 4:35 pm Purchase | 2026-03-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Alyeska Investment Group, L.P. | 394,668 9.990% | 319,040 (+421.85%) | Filing History |
| 2026-05-15 4:30 pm Sale | 2026-03-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Nantahala Capital Partners Limited Partnership | 148,736 3.388% | -40,969 (-21.60%) | Filing History |
| 2026-02-11 2:00 pm Unchanged | 2025-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Rosalind Advisors, Inc. | 464,676 9.900% | 0 (Unchanged) | Filing History |
| 2026-01-29 8:28 pm Sale | 2025-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Orin Hirschman | 192,984 4.900% | -62,571 (-24.48%) | Filing History |
| 2025-11-14 4:31 pm Purchase | 2025-09-30 | 13G | KIORA PHARMACEUTICALS INC KPRX | Nantahala Capital Management LLC | 363,712 9.990% | 57,450 (+18.76%) | Filing History |
| 2025-08-14 7:47 pm Purchase | 2025-06-30 | 13G | KIORA PHARMACEUTICALS INC KPRX | ADAR1 Capital Management LLC | 365,179 9.900% | 50,076 (+15.89%) | Filing History |
| 2025-08-14 4:36 pm Purchase | 2025-08-08 | 13G | KIORA PHARMACEUTICALS INC KPRX | Nantahala Capital Partners Limited Partnership | 189,705 5.299% | 189,705 (New Position) | Filing History |
| 2025-08-13 1:56 pm Sale | 2025-06-30 | 13G | KIORA PHARMACEUTICALS INC KPRX | Rosalind Advisors, Inc. | 464,676 9.900% | -250,555 (-35.03%) | Filing History |
| 2025-02-14 4:25 pm Sale | 2024-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Alyeska Investment Group, L.P. | 75,628 2.500% | -180,780 (-70.50%) | Filing History |
| 2025-02-12 11:39 am Sale | 2024-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | THE GOLDMAN SACHS GROUP, INC. GS | 130 0.000% | -180,662 (-99.93%) | Filing History |
| 2025-02-10 4:03 pm Purchase | 2024-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Rosalind Advisors, Inc. | 715,231 9.900% | 250,554 (+53.92%) | Filing History |
| 2025-02-10 08:38 am Sale | 2024-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Orin Hirschman | 255,555 8.500% | -2,044,445 (-88.89%) | Filing History |
| 2024-11-14 7:17 pm Purchase | 2024-09-30 | 13G | KIORA PHARMACEUTICALS INC KPRX | Lind Global Fund II LP | 109,160 3.500% | 15,271 (+16.26%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | KIORA PHARMACEUTICALS INC KPRX | Nantahala Capital Management LLC | 306,262 9.990% | 306,262 (New Position) | Filing History |
| 2024-11-14 4:45 pm Purchase | 2024-09-30 | 13G | KIORA PHARMACEUTICALS INC KPRX | ADAR1 Capital Management LLC | 315,103 9.990% | 315,103 (New Position) | Filing History |